Are lipid ratios and triglyceride-glucose index associated with critical care outcomes in COVID-19 patients?
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
05
01
2022
accepted:
11
07
2022
entrez:
1
8
2022
pubmed:
2
8
2022
medline:
4
8
2022
Statut:
epublish
Résumé
Lipid ratios and the triglyceride and glucose index (TyG) could be a simple biochemical marker of insulin resistance (IR). The current study was carried out to examine the correlation between triglyceride to high-density lipoprotein-cholesterol (TG/HDL-C), total cholesterol to HDL-C (TC/HDL-C), low-density lipoprotein-cholesterol to HDL-C ratio (LDL-C/HDL-C), as well as TyG index with the severity and mortality of severe coronavirus disease 2019 (COVID-19). A total of 1228 confirmed COVID-19 patients were included in the current research. Regression models were performed to evaluate the correlation between the lipid index and severity and mortality of COVID-19. The TyG index and TG/HDL-C levels were significantly higher in the severe patients (P<0.05). TG/HDL-C, LDL-C/HDL-C, TC/HDL-C ratios, and TyG index were significantly lower in survivor cases (P<0.05). Multivariate logistic regression analysis demonstrated that predictors of the severity adjusted for age, sex and BMI were TyG index, TG/HDL-C ratio (OR = 1.42 CI:1.10-1.82, OR = 1.06 CI: 1.02-1.11, respectively). This analysis showed that TG/HDL-C, TC/HDL-C, LDL-C/HDL-C ratios, and TyG index statistically are correlated with COVID-19 mortality (OR = 1.12 CI:1.06-1.18, OR = 1.24 CI:1.05-1.48, OR = 1.47 CI:1.19-1.80, OR = 1.52 CI:1.01-2.31, respectively). In summary, the TyG index and lipid ratios such as TC/HDL-C, TG/HDL-C, LDL-C/HDL-C could be used as an early indicator of COVID-19 mortality. Furthermore, the study revealed that TyG index and TG/HDL-C indices are biochemical markers of COVID-19 severe prognosis.
Identifiants
pubmed: 35913952
doi: 10.1371/journal.pone.0272000
pii: PONE-D-22-00381
pmc: PMC9342722
doi:
Substances chimiques
Biomarkers
0
Blood Glucose
0
Cholesterol, HDL
0
Cholesterol, LDL
0
Triglycerides
0
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0272000Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist
Références
Cold Spring Harb Perspect Biol. 2014 Jan 01;6(1):
pubmed: 24384568
Diabetes Care. 2021 Sep;44(9):2149-2157
pubmed: 34253561
J Lipid Atheroscler. 2020 Sep;9(3):435-448
pubmed: 33024735
J Pers Med. 2021 Mar 22;11(3):
pubmed: 33809913
MMWR Morb Mortal Wkly Rep. 2020 Apr 03;69(13):382-386
pubmed: 32240123
Ann Pediatr Endocrinol Metab. 2019 Mar;24(1):41-48
pubmed: 30943679
Am J Cardiol. 2005 Aug 1;96(3):399-404
pubmed: 16054467
Lipids Health Dis. 2010 Aug 17;9:85
pubmed: 20712907
Sci Rep. 2021 Dec 20;11(1):24224
pubmed: 34930966
Metab Syndr Relat Disord. 2018 Feb;16(1):6-12
pubmed: 29148894
Diabetes Care. 2008 Apr;31(4):783-8
pubmed: 18174496
Lipids Health Dis. 2020 Nov 8;19(1):235
pubmed: 33161896
Clin Med Insights Endocrinol Diabetes. 2021 Mar 24;14:1179551421990675
pubmed: 35173508
Front Nutr. 2021 Mar 18;8:610765
pubmed: 33816536
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):1463-1465
pubmed: 32771919
Dis Markers. 2019 Jun 11;2019:6891537
pubmed: 31281548
Clin Nutr ESPEN. 2021 Aug;44:437-444
pubmed: 34330502
PLoS One. 2015 Jan 30;10(1):e0116110
pubmed: 25635876
Front Public Health. 2021 Aug 18;9:705916
pubmed: 34490188
Cardiovasc Diabetol. 2014 Oct 20;13:146
pubmed: 25326814
World J Diabetes. 2010 May 15;1(2):36-47
pubmed: 21537426
Clin Nutr ESPEN. 2021 Oct;45:91-101
pubmed: 34620375
Endocr Pract. 2020 Jun 2;26(6):668-674
pubmed: 32357072
Cardiovasc Diabetol. 2019 Nov 13;18(1):150
pubmed: 31722708
BMC Endocr Disord. 2020 Jul 24;20(1):113
pubmed: 32709256
BMC Public Health. 2021 Feb 1;21(1):257
pubmed: 33522928
PLoS One. 2020 Oct 23;15(10):e0241265
pubmed: 33095835
Nat Rev Endocrinol. 2021 Jan;17(1):11-30
pubmed: 33188364
Research (Wash D C). 2020 Apr 19;2020:2402961
pubmed: 32377638
Diabetol Metab Syndr. 2021 Mar 01;13(1):23
pubmed: 33648564
Diabetes Res Clin Pract. 2020 Jun;164:108185
pubmed: 32360710
Cardiovasc Diabetol. 2020 May 11;19(1):58
pubmed: 32393351
Diabetes Metab J. 2020 Aug;44(4):602-613
pubmed: 32794386
Diabetes Care. 2004 Feb;27(2):314-9
pubmed: 14747206
Am J Physiol. 1979 Sep;237(3):E214-23
pubmed: 382871
Lipids Health Dis. 2018 Jul 18;17(1):158
pubmed: 30021597
Lipids Health Dis. 2017 Jan 19;16(1):15
pubmed: 28103934
Med Sci Monit. 2019 Jan 26;25:746-753
pubmed: 30683836
Allergy. 2020 Jul;75(7):1730-1741
pubmed: 32077115
J Gerontol A Biol Sci Med Sci. 2020 Oct 15;75(11):2224-2230
pubmed: 32687551
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Front Public Health. 2020 May 12;8:184
pubmed: 32574288
J Intern Med. 1998 Apr;243(4):293-8
pubmed: 9627143
Arch Med Res. 2021 Oct;52(7):738-745
pubmed: 33926762
Ir J Med Sci. 2021 Nov;190(4):1321-1333
pubmed: 33449333
Arch Bone Jt Surg. 2020 Apr;8(Suppl 1):247-255
pubmed: 32733980
Open Heart. 2020 Sep;7(2):
pubmed: 32938758
Endocrinol Nutr. 2014 Dec;61(10):533-40
pubmed: 25174769
Prev Med. 2016 May;86:99-105
pubmed: 26854766